| 03.02.2025 13:28 | AREC | Arecor Therapeutics confident for the future as revenue rises | Alliance |
| 03.02.2025 07:00 | AREC | Arecor Full Year 2024 Trading Update | RNS |
| 10.01.2025 21:21 | AREC | IN BRIEF: Arecor Therapeutics shares tumble as plans Tetris wind-down | Alliance |
| 10.01.2025 07:45 | AREC | Orderly Cessation of Tetris Pharma Operations | RNS |
| 09.01.2025 07:00 | AREC | Change of Nominated Advisor and Joint Broker | RNS |
| 30.12.2024 11:44 | AREC | IN BRIEF: Arecor Therapeutics signs new drug licensing agreement | Alliance |
| 30.12.2024 07:00 | AREC | Arecor Signs Exclusive Licensing Agreement | RNS |
| 02.12.2024 07:00 | AREC | Grant of Options and PDMR Dealing | RNS |
| 18.11.2024 14:29 | AREC | IN BRIEF: Arecor Therapeutics names David Ellam as interim CFO | Alliance |
| 27.09.2024 07:00 | AREC | Arecor to present on Investor Meet Company | Reach |
| 26.09.2024 19:33 | HSD, ENET, FLO | EARNINGS: Hansard Global profit down; Flowtech cuts outlook | Alliance |
| 26.09.2024 07:00 | AREC | Interim Results for six months ended 30 June 2024 | RNS |
| 19.09.2024 15:17 | AREC | Notice of Results | RNS |
| 11.09.2024 07:00 | AREC | Arecor presents positive AT278 data at EASD | RNS |
| 03.09.2024 07:00 | AREC | Arecor announces AT278 presentation at EASD 2024 | Reach |
| 22.08.2024 16:34 | AREC | Holding(s) in Company | RNS |
| 20.08.2024 13:44 | OXH, AREC | Holding(s) in Company | RNS |
| 12.08.2024 15:02 | AREC | Holding(s) in Company | RNS |
| 08.08.2024 14:48 | AREC | Result of General Meeting and Total Voting Rights | RNS |
| 23.07.2024 16:26 | AREC | Posting of Circular and General Meeting | RNS |
| 23.07.2024 07:00 | AREC | Result of WRAP Retail Offer | RNS |
| 19.07.2024 19:34 | AREC, PALM, SWG | TRADING UPDATES: Ingenta and Shearwater win deals | Alliance |
| 19.07.2024 18:22 | AREC | Result of Placing and Subscription | RNS |
| 19.07.2024 13:17 | AREC | WRAP Retail Offer to raise up to £1 million | RNS |
| 19.07.2024 13:10 | AREC | Proposed Placing and Subscription | RNS |
| 28.06.2024 14:35 | AREC | Result of AGM | RNS |
| 21.06.2024 15:18 | ZEG, XLM, VLE | UK shareholder meetings calendar - next 7 days | Alliance |
| 14.06.2024 19:47 | AREC, OXH, BSV | EARNINGS AND TRADING: Sound Energy sells part of Moroccan assets | Alliance |
| 10.06.2024 10:32 | AGY, MSMN, AREC | AIM WINNERS & LOSERS: Arecor Therapeutics dives on funding needs | Alliance |
| 10.06.2024 09:54 | AREC | Arecor Therapeutics shares dive as says needs funding in third quarter | Alliance |
| 10.06.2024 07:00 | AREC | Trading and Funding Update | RNS |
| 31.05.2024 16:05 | AREC | Posting of 2023 Annual Report and Notice of AGM | RNS |
| 23.05.2024 07:00 | AREC | Grant of Options and PDMR Dealing | RNS |
| 21.05.2024 07:00 | AREC | Arecor to host company and KOL webinar today | RNS |
| 20.05.2024 09:58 | AREC | Arecor Therapeutics hails positive profile for insulin AT278 | Alliance |
| 20.05.2024 07:00 | AREC | Positive headline results for AT278 clinical trial | RNS |
| 16.05.2024 14:32 | AREC, IKA, DXRX | EARNINGS AND TRADING: Michelmersh continues with positive order intake | Alliance |
| 16.05.2024 07:00 | AREC | Final results for 2023 | RNS |
| 14.05.2024 10:17 | AREC | Notice of Results | RNS |
| 09.05.2024 17:18 | AREC | Arecor Therapeutics collaborates with Medtronic on novel insulin | Alliance |
| 09.05.2024 07:00 | AREC | Arecor and Medtronic Diabetes collaboration | RNS |
| 03.05.2024 18:02 | AREC | IN BRIEF: Arecor Therapeutics delays publication of 2023 results | Alliance |
| 03.05.2024 16:44 | AREC | Publication of Full Year Financial Results delayed | RNS |
| 30.04.2024 14:38 | IWG, MXCT, KOS | UK earnings, trading statements calendar - next 7 days | Alliance |
| 29.04.2024 07:00 | AREC | Notice of results | RNS |
| 23.04.2024 11:02 | AREC | Arecor chief financial officer to leave in July after five years | Alliance |
| 23.04.2024 07:00 | AREC | BOARD CHANGE | RNS |
| 12.03.2024 12:16 | AREC | Arecor to develop "holy grail" diabetes treatment with partner TRx | Alliance |
| 12.03.2024 08:58 | AREC | Arecor and TRx Biosciences research collaboration | RNS |
| 12.03.2024 07:00 | AREC | Arecor and TRx Biosciences research collaboration | Reach |
| 29.02.2024 19:42 | AREC, ENSI, BCE | EARNINGS AND TRADING: East Star, Getech strike Kazakhstan JV | Alliance |
| 29.02.2024 07:00 | AREC | Arecor announces launch of Ogluo® in Netherlands | RNS |
| 01.02.2024 14:24 | AREC | Arecor Therapeutics hails Arestat as 2023 performance "strong" | Alliance |
| 23.01.2024 21:47 | AREC | IN BRIEF: Arecor pleased as investee Inhibrx sells therapy to Sanofi | Alliance |
| 23.01.2024 16:58 | AREC | Arecor announces update on INBRX-101 | RNS |
| 18.01.2024 18:26 | VTY, SHEL, KIST | TRADING UPDATES: Patent boosts for DG Innovate and Arecor Therapeutics | Alliance |
| 18.01.2024 07:00 | AREC | Arecor granted key European patent | RNS |
| 08.01.2024 11:34 | AREC | Arecor expands speciality hospital collaboration with partner | Alliance |
| 08.01.2024 07:00 | AREC | Expansion of specialty hospital collaboration | RNS |
| 03.01.2024 07:00 | AREC | Appointment of SVP for Tetris Pharma Ltd | RNS |
| 04.12.2023 15:42 | AREC | Arecor inks co-development deal with global medical company | Alliance |
| 04.12.2023 07:00 | AREC | Agreement with global medical products company | RNS |
| 29.11.2023 14:28 | AREC, EQT, SBDS | TRADING UPDATES: Arecor inks Eli Lilly deal; RBG appoints McNair CFO | Alliance |
| 29.11.2023 07:00 | AREC | Arecor Continues Collaboration with Lilly | RNS |
| 17.11.2023 11:45 | AREC | IN BRIEF: Arecor Therapeutics gets "milestone payment" from AT220 sale | Alliance |
| 17.11.2023 07:00 | AREC | Product with Arestat technology launched in Europe | RNS |
| 02.11.2023 21:01 | MET1, AREC | TRADING UPDATES: Troy Income suspends buyback of shares | Alliance |
| 02.11.2023 07:00 | AREC | Inhibrx milestone triggers payment to Arecor | RNS |
| 01.11.2023 15:31 | AREC | Exercise of rollover options & Total Voting Rights | RNS |
| 02.10.2023 11:11 | AREC | Arecor Therapeutics ups subject numbers for insulin-focused trial | Alliance |
| 02.10.2023 07:00 | AREC | Progress of Phase I clinical study of AT278 | RNS |
| 22.09.2023 13:05 | SCLP, AREC, OXH | IN BRIEF: Oxford Technology 2 VCT asset value hurt by AIM share falls | Alliance |
| 15.09.2023 07:00 | AREC | Arecor on Investor Meet Company Platform | Reach |
| 14.09.2023 12:05 | CHSS, AREC, RNEW | EARNINGS: Jersey O&G and World Chess losses widen, Arecor narrows | Alliance |
| 14.09.2023 07:00 | AREC | Interim Results for six months ended 30 June 2023 | RNS |
